SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination

The receptor‐binding domain (RBD) of the SARS‐CoV‐2 spike protein is a candidate vaccine antigen that binds angiotensin‐converting enzyme 2 (ACE2), leading to virus entry. Here, it is shown that rapid conversion of recombinant RBD into particulate form via admixing with liposomes containing cobalt‐p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Adv Mater
Egile Nagusiak: Huang, Wei‐Chiao, Zhou, Shiqi, He, Xuedan, Chiem, Kevin, Mabrouk, Moustafa T., Nissly, Ruth H., Bird, Ian M., Strauss, Mike, Sambhara, Suryaprakash, Ortega, Joaquin, Wohlfert, Elizabeth A., Martinez‐Sobrido, Luis, Kuchipudi, Suresh V., Davidson, Bruce A., Lovell, Jonathan F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645956/
https://ncbi.nlm.nih.gov/pubmed/33111375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adma.202005637
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak